‘Hated’ Pharma CEO Says Company to Lower Price of AIDS Drug

September 24, 2015 2:48 PM

34 1

The CEO of a pharmaceutical company that raised the price of a drug used by AIDS patients by over 4,000 percent is now saying his company will lower the price.

Martin Shkreli, the CEO of Turing pharmaceutical company, has been called the most hated man in America after it was learned his company had hiked the price of Daraprim, a drug used by patients with AIDS and certain types of cancer, from $13.50 to $700 a pill.

Also read: FDA approves BioMarin rare metabolic disorder drug, shares rise

Read more

To category page